These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 3181276)
1. The effect of platelet activating factor on nasal hypersensitivity. Andersson M; Pipkorn U Eur J Clin Pharmacol; 1988; 35(3):231-5. PubMed ID: 3181276 [TBL] [Abstract][Full Text] [Related]
2. Eosinophil chemotactic activity of topical PAF on the human nasal mucosa. Klementsson H; Andersson M Eur J Clin Pharmacol; 1992; 42(3):295-9. PubMed ID: 1577048 [TBL] [Abstract][Full Text] [Related]
3. Nasal neutrophilia and eosinophilia induced by challenge with platelet activating factor. Tedeschi A; Palumbo G; Milazzo N; Miadonna A J Allergy Clin Immunol; 1994 Feb; 93(2):526-33. PubMed ID: 8120279 [TBL] [Abstract][Full Text] [Related]
4. Study of the effects of paf-acether on human nasal airways. Leggieri E; Tedeschi A; Lorini M; Bianco A; Miadonna A Allergy; 1991 Aug; 46(6):466-71. PubMed ID: 1720286 [TBL] [Abstract][Full Text] [Related]
5. Evidence of PAF-acether metabolic pathway activation in antigen challenge of upper respiratory airways. Miadonna A; Tedeschi A; Arnoux B; Sala A; Zanussi C; Benveniste J Am Rev Respir Dis; 1989 Jul; 140(1):142-7. PubMed ID: 2546468 [TBL] [Abstract][Full Text] [Related]
6. Effects of inhaled furosemide on platelet-activating factor challenge in mild asthma. Echazarreta AL; Gómez FP; Ribas J; Achaval M; Barberà JA; Roca J; Chung KF; Rodriguez-Roisin R Eur Respir J; 1999 Sep; 14(3):616-21. PubMed ID: 10543284 [TBL] [Abstract][Full Text] [Related]
7. The effect of platelet-activating factor (PAF) on nasal airway resistance in healthy subjects is not mediated by nitric oxide. Maniscalco M; Sofia M; Faraone S; Carratù L Allergy; 2000 Aug; 55(8):757-61. PubMed ID: 10955702 [TBL] [Abstract][Full Text] [Related]
8. Effect of platelet activating factor on the human nasal mucosa. Pipkorn U; Karlsson G; Bake B Allergy; 1984 Feb; 39(2):141-5. PubMed ID: 6703263 [TBL] [Abstract][Full Text] [Related]
9. Platelet-activating factor nasal challenge induces nasal congestion and reduces nasal volume in both healthy volunteers and allergic rhinitis patients. Muñoz-Cano R; Valero A; Roca-Ferrer J; Bartra J; Sanchez-Lopez J; Mullol J; Picado C Am J Rhinol Allergy; 2013; 27(2):e48-52. PubMed ID: 23562190 [TBL] [Abstract][Full Text] [Related]
10. The effect of platelet-activating factor on the responsiveness of the human nasal airway. Austin CE; Foreman JC Br J Pharmacol; 1993 Sep; 110(1):113-8. PubMed ID: 8220870 [TBL] [Abstract][Full Text] [Related]
11. Nasal neutrophilia and release of myeloperoxidase induced by nasal challenge with platelet activating factor: different degrees of responsiveness in atopic and nonatopic subjects. Miadonna A; Milazzo N; Lorini M; Sala A; Tedeschi A J Allergy Clin Immunol; 1996 Apr; 97(4):947-54. PubMed ID: 8655890 [TBL] [Abstract][Full Text] [Related]
12. Excretion of platelet activating factor-acetylhydrolase and phospholipase A2 into nasal fluids after allergenic challenge: possible role in the regulation of platelet activating factor release. Touqui L; Herpin-Richard N; Gene RM; Jullian E; Aljabi D; Hamberger C; Vargaftig BB; Dessange JF J Allergy Clin Immunol; 1994 Jul; 94(1):109-19. PubMed ID: 8027488 [TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor does not induce bronchial hyperreactivity in nonasthmatic subjects. Gebremichael I; Leuenberger P Respiration; 1992; 59(4):193-6. PubMed ID: 1485002 [TBL] [Abstract][Full Text] [Related]
14. Platelet activating factor stimulates rapid mucin secretion in rat nasal airways in vivo. Hotchkiss JA; Stam MA; Harkema JR Exp Lung Res; 1993; 19(5):545-57. PubMed ID: 8253058 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of nasal symptoms induced by platelet activating factor, after nasal challenge in both healthy and allergic rhinitis subjects pretreated with rupatadine, levocetirizine or placebo in a cross-over study design. Muñoz-Cano R; Valero A; Izquierdo I; Sánchez-López J; Doménech A; Bartra J; Mullol J; Picado C Allergy Asthma Clin Immunol; 2013 Nov; 9(1):43. PubMed ID: 24499312 [TBL] [Abstract][Full Text] [Related]
16. Effect of nedocromil sodium on allergen-, PAF-, histamine- and bradykinin-induced airways vasodilatation and pulmonary obstruction in the pig. Alving K; Matran R; Lundberg JM Br J Pharmacol; 1991 Oct; 104(2):452-8. PubMed ID: 1665736 [TBL] [Abstract][Full Text] [Related]
17. [Effects of anti-PAF agents on nasal response after allergen challenge in guinea pigs]. Narita S; Asakura K; Shirasaki H; Kojima T; Saitoh H; Kataura A Nihon Jibiinkoka Gakkai Kaiho; 1992 Aug; 95(8):1190-7. PubMed ID: 1357119 [TBL] [Abstract][Full Text] [Related]
18. Attenuation of allergen-evoked nasal responses by local pretreatment with exogenous neuropeptide Y in atopic patients. Lacroix JS; Mosimann BL J Allergy Clin Immunol; 1996 Sep; 98(3):611-6. PubMed ID: 8828539 [TBL] [Abstract][Full Text] [Related]
19. Changes in bronchial responsiveness, circulating leucocytes and ex vivo cytokine production by blood monocytes after PAF inhalation in allergic asthmatics. Louis R; Degroote D; Bury T; Corhay JL; Kayembe JM; Franchimont P; Radermecker MF Eur Respir J; 1995 Apr; 8(4):611-8. PubMed ID: 7664863 [TBL] [Abstract][Full Text] [Related]
20. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. Corren J; Adinoff AD; Buchmeier AD; Irvin CG J Allergy Clin Immunol; 1992 Aug; 90(2):250-6. PubMed ID: 1500629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]